This inventor holds 2 USPTO granted patents. Top assignee: Genetronics, Inc.. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2004
Title: Günter A Hofmann: Innovator in Electroporation Technology
Introduction
Günter A Hofmann is a notable inventor based in San Diego, CA. He has made significant contributions to the field of electroporation technology, particularly in the delivery of drugs and genes into tissue. With a total of 2 patents, Hofmann's work has the potential to impact medical treatments and research.
Latest Patents
Hofmann's latest patents include an "Electrode apparatus and method for the delivery of drugs and genes into tissue." This invention features an electrode assembly designed for trans-surface molecular delivery, incorporating a non-conductive carrier with multiple electrodes and conductors to apply an electric field to tissue surfaces. Another significant patent is the "Electroporation apparatus with connective electrode template," which consists of a three-dimensional support member with needle electrodes that can be selectively extended into tissue for electroporation, connecting to a power supply for effective treatment.
Career Highlights
Günter A Hofmann has been instrumental in advancing electroporation technology through his innovative designs and methodologies. His work at Genetronics, Inc. has positioned him as a key figure in the development of medical devices aimed at improving drug and gene delivery systems.
Collaborations
Hofmann has collaborated with notable colleagues, including Dietmar P Rabussay and Zei Zhang, contributing to the advancement of electroporation techniques and their applications in medicine.
Conclusion
Günter A Hofmann's contributions to electroporation technology highlight his role as an innovator in the medical field. His patents reflect a commitment to enhancing drug and gene delivery methods, which may lead to significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile